TEPMETKO® (tepotinib) PATIENT ASSISTANCE PROGRAM

CoverOne includes a Patient Assistance Program (PAP) that provides TEPMETKO® (tepotinib) at no charge to patients who meet certain insurance (i.e., uninsured), income, and residency eligibility criteria.

  • To determine patient eligibility, providers should complete and submit the CoverOne TEPMETKO Enrollment Form prior to treatment. Patient assistance is not applied retroactively.
  • An Access Navigator will notify you as soon as possible about the patient’s eligibility status.
  • If eligible, the CoverOne PAP will ship the free supply of TEPMETKO to the patient

Please include the most recent tax return (e.g., IRS Form 1040) if applying for the Patient Assistance Program.

 

NOTE: The CoverOne patient assistance program is a philanthropic program for patients in need, and is not contingent on any past or future commercial sale.